Medcorp (TRN:MED) Current Deferred Revenue: TTD0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TRN:MED Medcorp Ltd TRN:MED
42 GF Score
Price TTD36.70
! 1 Warning Sign
View Full Analysis

What is Medcorp Current Deferred Revenue?

Medcorp TRN:MED 42 Current Deferred Revenue is TTD0.00 Mil as of . 20. GuruFocus rates TRN:MED with a GF Score™ of 42/100. The stock has 1 warning sign investors should review.

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Medcorp's current deferred revenue for the quarter that ended in . 20 was TTD0.00 Mil.

Medcorp Current Deferred Revenue Related Terms

Medcorp Current Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Medcorp's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medcorp Current Deferred Revenue Chart

Medcorp Annual Data
Trend
Current Deferred Revenue

Medcorp Semi-Annual Data
Current Deferred Revenue
TRN:MED
42GF Score
Medcorp Ltd TRN:MED
Current Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Revenue of TTD0.00 Mil mean?
Medcorp (TRN:MED) has a Current Deferred Revenue of TTD0.00 Mil as of . 20. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Medcorp and its competitors.
Is Medcorp's Current Deferred Revenue too high?
Medcorp's current Current Deferred Revenue is TTD0.00 Mil. Overall, Medcorp has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Medcorp's Current Deferred Revenue compare to HCA and THC?
Medcorp's Current Deferred Revenue of TTD0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Revenue for a Healthcare Providers & Services company?
A good Current Deferred Revenue depends on the Healthcare Providers & Services industry context. However, Current Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Revenue mean?
A high Current Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Current Deferred Revenue records the total amount of cash received for unfinished services. View historical data on Medcorp and its competitors. Medcorp's current Current Deferred Revenue is TTD0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medcorp stock overvalued right now?
Medcorp (TRN:MED) has a current Current Deferred Revenue of TTD0.00 Mil. The current Current Deferred Revenue is TTD0.00 Mil. Medcorp's overall GF Score™ is 42/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Revenue calculated?
Current Deferred Revenue is calculated from a company's financial statements. For Medcorp (TRN:MED), the current Current Deferred Revenue is TTD0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medcorp Business Description

Address 18 Elizabeth Street, Saint Clair, Port-of-Spain, TTO
Medcorp Ltd operates as a private healthcare facility in the Republic of Trinidad and Tobago. The company's main business is the operation of a private hospital, the provision of radiology services, and the provision of cancer treatment services. Its services include 24-Hour Accident & Emergency, Diagnostic Services, Dialysis Service, Executive Health Assessment, Intensive Care Unit, Maternity & Nursery Services, Nursing Care Services, Pharmacy Services, Support Services, and Surgical Services.
42GF Score

Get the complete analysis for TRN:MED

Current Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

TTD36.70
Price